YTHDF1 and hepatocellular carcinoma: COX regression analysis for risk score and clinical features confirmed that YTHDF2, YTHDF1, METTL3, KIAA1429, and ZC3H13 could serve as markers to predict prognosis and may even be targeted in novel therapies of HCC.